Glonoinum 6 X (DIN 02233766) — Cancelled Post Market in Canada

Q: Is Nitroglycerin registered outside Canada?

Yes — 148 matched registrations in 4 other markets.

Glonoinum 6 X Drops ; Globules ; Granules ; Liquid ; Pellet ; Tablet is a Health Canada–registered human drug (DIN 02233766) held by Seroyal International Inc., containing Nitroglycerin. Health Canada lists its status as Cancelled Post Market (status date 06 Jul 2009). Nexara Health has matched 148 registrations of Nitroglycerin across 4 other regulated markets, 12 of them in the same strength and dosage form.

Health Canada registration

DIN	02233766
Brand name	Glonoinum
Active ingredient	Nitroglycerin
Strength	6 X
Dosage form	Drops ; Globules ; Granules ; Liquid ; Pellet ; Tablet
Route	Oral
Company	Seroyal International Inc.
Status	Cancelled Post Market — 06 Jul 2009
Class	Human
ATC
AHFS	92:02.00* ; See footnote
Regulator record	Health Canada DPD entry · Product monograph

Nitroglycerin registered in other markets

148 registrations of the same molecule in 4 national registries outside Canada (first 28 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.

Country	Product	Marketing authorisation holder	Strength	Form	Status	Registry
Taiwan	Nitroglycerin Tablets "Nysco"	尼斯可股份有限公司新莊廠		錠劑	已註銷	TFDA
Taiwan	Nitroglyn Tablets 1/10gr.	Forest Lab. Inc. Distributed By Key Corp.		錠劑	已註銷	TFDA
Taiwan	Nitroglyn Tablets 1/25gr.	Forest Lab. Inc. Distributed By Key Corp.		錠劑	已註銷	TFDA
Taiwan	Nitrong	U.s. Ethicals Inc.		錠劑	已註銷	TFDA
United States	nitroglycerin	Medical Purchasing Solutions, LLC		Tablet	listed	FDA NDC
United States	nitroglycerin	NorthStar RxLLC		Tablet	listed	FDA NDC
United States	nitroglycerin	Redpharm Drug		Tablet	listed	FDA NDC
United States	nitroglycerin	Lifestar Pharma LLC		Tablet	listed	FDA NDC
United States	nitroglycerin	Lifestar Pharma LLC		Tablet	listed	FDA NDC
United States	nitroglycerin	Remedyrepack Inc.		Tablet	listed	FDA NDC
United States	nitroglycerin	Lifestar Pharma LLC		Tablet	listed	FDA NDC
United States	Nitroglycerin	Golden State Medical Supply, Inc.		Tablet	listed	FDA NDC
Romania	NITROGLICERINA 0,5 mg	—	0,5mg	Compr. Subling.	P6L	ANMDMR nomenclator
Romania	NITROMINT 0,4 mg/doza	—	0,4mg/doza	Spray Sublingual	P6L	ANMDMR nomenclator
Romania	NITROMINT 2,6 mg	—	2,6mg	Compr. Cu Elib. Prel.	P6L	ANMDMR nomenclator
Romania	NITRONAL 1 mg/ml	—	1mg/ml	Sol. Perf.	PR	ANMDMR nomenclator
Romania	NITRONAL 1 mg/ml	—	1mg/ml	Sol. Perf.	PR	ANMDMR nomenclator
Romania	NITRONAL 1 mg/ml	—	1mg/ml	Sol. Perf.	PR	ANMDMR nomenclator
Saudi Arabia	Netrosan	—	0.4		Inactive	SFDA
Saudi Arabia	Nitroderm Tts 5 Patches	—	25		Inactive	SFDA
Saudi Arabia	Nitroderm Tts 5 Patches	—	25		Inactive	SFDA
Saudi Arabia	Nitroderm Tts-10 System	—	50		Inactive	SFDA
Saudi Arabia	Nitroderm Tts-10 System	—	50		Inactive	SFDA
Saudi Arabia	Retrosin Ointment	—	0.4		Inactive	SFDA
Taiwan	Goyceryl Trinitrate For Injection "Dbl"	David Bull Laboratories		注射劑	已註銷	TFDA
Taiwan	Mifiry Injection	杏林新生製藥股份有限公司		注射劑	Registered	TFDA
Taiwan	Millisrol Injection	Takasaki Plant, Nippon Kayaku Co., Ltd.		注射劑	Registered	TFDA
Taiwan	Minitran Transdermal Delivery System 0.2mg/Hr	3m Pharmaceuticals		穿皮貼片劑	已註銷	TFDA

See every manufacturer of Nitroglycerin worldwide →

Regulator price references for Nitroglycerin

Published list or reimbursement prices for Nitroglycerin presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.

Country	Product	Price	Type	Source	As of
Saudi Arabia	Nitroderm Tts 5 Patches	17.60 SAR	public	SFDA	2026-09-01
Saudi Arabia	Nitroderm Tts-10 System	33.75 SAR	public	SFDA	2026-09-01
Saudi Arabia	Nitroderm Tts 5 Patches	58.30 SAR	public	SFDA	2026-09-01
Saudi Arabia	Nitroderm Tts-10 System	62.60 SAR	public	SFDA	2026-09-01
Saudi Arabia	Netrosan	76.45 SAR	public	SFDA	2026-09-01
Saudi Arabia	Retrosin Ointment	91.40 SAR	public	SFDA	2026-09-01

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Glonoinum (DIN 02233766) marketed in Canada?

No. Health Canada lists DIN 02233766 as Cancelled Post Market as of 06 Jul 2009.

Who holds the Canadian licence for this product?

Seroyal International Inc. is the company of record in the Health Canada Drug Product Database.

Is Nitroglycerin registered outside Canada?

Yes — Nexara Health has matched 148 registrations in 4 other markets, including 12 in the same strength and dosage form (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02233766, status date 2009-07-06; national medicine registries: ANMDMR nomenclator, FDA NDC, SFDA, TFDA; price sources: SFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02233766, status date 2009-07-06; national medicine registries: ANMDMR nomenclator, FDA NDC, SFDA, TFDA; price sources: SFDA.

Seroyal International Inc. — company profile Who else makes Nitroglycerin All Canadian Nitroglycerin products

Health Canada Drug Product Database (DPD), DIN 02233766, status date 2009-07-06; national medicine registries: ANMDMR nomenclator, FDA NDC, SFDA, TFDA; price sources: SFDA. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.